Imagine being able to see the invisible-amyloid plaques, tau tangles, and metabolic changes in the living brain. This is no ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to ...

SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid ...

Researchers are slowly tossing much of what we've been told for many years about Alzheimer's disease out the window — and replacing what has been a very dreary tale with new findings.

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers (BBMs).

Can driving patterns help predict cognitive decline later in life? A new study finds that certain changes in driving habits ...

Abstract: Early and accurate diagnosis of Alzheimer's disease (AD) is critical for effective intervention. We propose GINEVGAE(Modified Graph Isomorphism Network with Variational Graph Autoencoder, a ...

Alzheimer's researchers believe a cure for the brain disease could be closer than many think. Researchers at the University ...

The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...

After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...